ResearcherAffiliated Zhongshan Hospital of Dalian UniversityActive in the last 2 years

Hongliang Chang

Verified by OpenAlex author ID (good confidence)As of 14 November 2026

Matched on OpenAlex author ID A5102657189.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 1, last author 0)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer. First author DOI 10.1038/s41598-024-60780-6 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Hong Chen · 1 shared paper, 2024
- Paper Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer. DOI 10.1038/s41598-024-60780-6 ↗
Deguang Sun · 1 shared paper, 2024
- Paper Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer. DOI 10.1038/s41598-024-60780-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.